Expert Insights
Content Hubs
Themes
Active ETFs
Free Cash Flow
Alternatives
Future ETFs
Artificial Intelligence
Innovative ETFs
China Insights
Institutional Income Strategies
CoinShares
Leveraged & Inverse
Core Strategies
Market Insights
Crypto
Market Outlooks
Disruptive Technology
Modern Alpha
Energy Infrastructure
Nuclear Energy
ETF Building Blocks
Portfolio Strategies
ETF Investing
Sector Investing
ETF Strategist
Tax Efficient Income
Financial Literacy
Thematic Investing
Fixed Income
Asset Class
Equity
Emerging Market Equities
Int'l Developed
U.S. Equity
Fixed Income
High Yield Corporates
Int'l Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
Alternatives
Gold/Silver/Critical Materials
Cryptocurrency
Currency
Volatility
ETF Ecosystem
ETFs in Canada
Market Outlook
Exchange
CoinShares
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
IEMG – iShares Core MSCI Emerging Markets ETF
EEM – iShares MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
Gaining Perspective
ETF 360 Video Series
Sectors
Sector Investing Content Hub
Sector Power Rankings
XLK
XLE
XLI
XLC
XLU
XLF
XLY
XLV
XLP
XLB
XLRE
Events
Asset Allocation Summit
Midyear Market Outlook
2027 Market Outlook
Q2 Market Outlook
Winter Symposium
Company
About VettaFi
Get VettaFi’ed
PBE
Featured
More Upside Possible for Biotech ETF
By
Todd Shriber
May 6, 2014
Featured
Biotech Bumble: ETFs Fall to 2014 Lows
By
Todd Shriber
April 10, 2014
Featured
Investors Say Bye-Bye to Biotech ETFs
By
Todd Shriber
April 8, 2014
Featured
Big Biotech ETF Still in Uptrend…For Now
By
Tom Lydon
March 26, 2014
Featured
Health Care ETFs Raking in Plenty of Cash
By
Todd Shriber
March 6, 2014
Featured
Why This Biotech ETF Leads the Pack
By
Todd Shriber
February 21, 2014
Equity ETFs
Health Care Heaven: Sector’s ETFs Flex Their Muscles
By
Todd Shriber
February 14, 2014
Featured
The One ETF Really Benefiting From the Intercept Pharma News
By
Todd Shriber
January 9, 2014
Featured
Intense Duel to be 2013’s Best Health Care ETF
By
Tom Lydon
December 23, 2013
Featured
Biotech ETFs: More Tricks Than Treats in October
By
Max Chen
October 31, 2013
Featured
Sell-Off in Biotech ETFs Could Be a Temporary Setback
By
Tom Lydon
October 10, 2013
Featured
10 ETF Investments That Got the Most Bang for Your Buck
By
Tom Lydon
October 8, 2013
Featured
Three ETFs to Play Up-and-Coming Health Care Companies
By
Tom Lydon
September 3, 2013
Featured
Three ETFs to Play the Outperforming Biotech Sector
By
Tom Lydon
August 19, 2013
Featured
Choosing the Right Biotech ETF Exposure
By
Tom Lydon
April 20, 2012
Featured
Biotech ETFs Mixed After Gilead Subpoena
By
Tom Lydon
June 13, 2011
Featured
5 Biotechnology ETFs to Play Innovation
By
Tom Lydon
February 22, 2011
Featured
Why Health Care ETFs May Be In the Clear
By
Tom Lydon
November 10, 2010
Previous
1
2
3
4
Next
X